Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: Evidence for a dominant phenotype

Cancer Research

Volumn 56, Issue 13, 1996, Pages 3075-3086

  Bani, Maria Rosa ^a   Rak, Janusz ^a   Adachi, Dena ^a   Wiltshire, Rodney ^c   Trent, Jeffrey M ^c   Kerbel, Robert S ^a,b   Ben David, Yaacov ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; DNA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MELANOMA ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; CARCINOGENIC ACTIVITY; CONTROLLED STUDY; DNA CONTENT; DNA LIBRARY; DNA SEQUENCE; HUMAN; HUMAN CELL; HYBRID CELL; KARYOTYPE; MELANOMA; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD146; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CYTOKINES; DRUG RESISTANCE, MULTIPLE; HUMANS; HYBRID CELLS; KARYOTYPING; MELANOMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM STAGING; NEURAL CELL ADHESION MOLECULES; ONCOGENES; PHENOTYPE; RETROVIRIDAE INFECTIONS; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029941653     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Lee, J. A. H. The current rapid increase in incidence of mortality from malignant melanoma in developed societies Pigment Cell, 2: 414-420, 1976.
2. Clark, W. H , Elder, D. E , Guerry, D., Epstein, M N., Greene, M. H., and Van Horn, M. A study of nimor progression the precursor lesions of superficial spreading melanoma and nodular melanoma. Human Pathol., 15. 1147-1165, 1984.
3. Franceschi, S., La Vecchia, C , Lucchini, F , and Cristofolmi, M. The epidemiology of cutaneous malignant melanoma: etiology and European data. Eur. J. Cancer Prevent., 1: 9-22, 1991.
4. Elwood, J. M., and Koh, H K. Etiology, epidemiology, risk factors, and public health issues of melanoma. Curr Opin. Oncol., 6. 179-187, 1994.
5. Clark, W Tumor progression and the nature of cancer Br J Cancer, 64: 631-644, 1991
6. Guerry, D., Synnestvedt, M., Elder, D. E., and Schultz, D Lessons from tumor prosression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J. Invest. Dermatol., 100: 342-345, 1993.
7. Herlyn, M., Clark, W. H , Rodeck, U., Mancianu, M L., Jambrosic, J., and Koprowski, H. Biology of tumor progression in human melanocytes. Lab. Invest., 56: 461-474, 1987.
8. Kerbel, R. S Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv. Cancer Res , 55: 87-132, 1990.
9. Herlyn, M Human melanoma, development and prosression. Cancer Metastasis Rev., 9: 101-112, 1990.
10. Holzmann, B., Brocker, E B., Lehmann, J., Ruiter, D J., Sorg, C., Reithmuller, G., and Johnson, J. Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes. Int J Cancer, 39: 446-471, 1987.
11. Kobayashi, H , Man, S., MacDougall, J. R., Graham, C. H., Lu, C , and Kerbel, R S. Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine resistant phenotype. Am. J. Pathol., 144: 776-786, 1994
12. Herlyn, M , Kath, R., Williams, N , Valyi-Nagy, I., and Rodeck, U. Growth regulatory factors for normal, premalignant, and malignant human cells in vitro. Adv. Cancer Res , 54: 213-234, 1989
13. Kath, R , Rodeck, U , Parmiter, A., and Herlyn, M Growth factor independence in vitro of primary melanoma cells from advanced but not early or intermediate lesions Cancer Therapy Control, 1 179-191, 1991
14. van Lohuizen, M., and Berns, A. Tumorigenesis by slow-transforming retrovirus-es - an update Biochim Biophys Acta, 1032: 213-235, 1990.
15. Peters, G Oncogenes at viral integration sites. Cell Growth & Differ , 1. 503-510, 1990.
16. Ben-David, Y., and Bernstein, A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell, 66: 831-834, 1991
17. Habets, G. G M., Scholtes, E. H. M., Zuydgeest, D., van der Kammen, R. A., Stam, J. C., Berns, A., and Collard, J. G Identification with an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for rho-like proteins. Cell, 77: 537-549, 1994
18. Dorssers, L. C. J., van Agthoven, T , Dekker, A , van Agthoven, T. L. A., and Kok, E. M Induction of antiestrogen resistance in human breast cancer cells by random insertional mutagenesis using defective retroviruses: identification of bcar-1, a common integration site. Mol Endocrinol., 7: 870-878, 1993.
19. Lu, S-J., Man, S., Bani, M R , Adachi, D., Hawley, R. G., Kerbel, R. S., and Ben-David, Y. Retroviral insertional mutagenesis as a strategy for the identification of genes associated with cis-diamminedichloroplatinum(II) resistance Cancer Res., 55 1139-1145, 1995
20. Markowitz, D , Goff, S , and Bank, A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology, 167: 400-406, 1988.
21. Hawley, R G., Fong, A. Z. C., Burns, B. F., and Hawley, T. S. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J. Exp. Med , 176: 1149-1163, 1992.
22. Cornil, I., Man, S., Fernandez, B., and Kerbel, R S. Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice J. Natl. Cancer Inst., 81: 938-944, 1989.
23. Albino, A P., Sozzi, G., Nanus, D. M., Jhanwar, S. C., and Houghton, A N. Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype Oncogene, 7: 2315-2321, 1992.
24. MacDougall, J., and Kerbel, R S. Responsiveness of normal/dysplastic melanocytes and melanoma cells from different lesional stages of disease progression to the growth inhibitory effects of TGF-β Mol. Cell. Differ., 1, 21-40, 1993
25. Johnson, J P., Stade, B G , Holzmann, B., Schwable, N., and Reithmuller, G. De novo expression of intercellular adhesion molecule 1 in melanoma correlates with increased risk of metastasis Proc Natl Acad. Sci. USA, 86 641-644, 1989.
26. Lehmann, J M., Holzmann, B., Breitbart, E. W., Schmiegelow, P , Riethmuller, G., and Johnson, J. P. Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with molecular weight of 76,000 Cancer Res , 47 841-845, 1987
27. Quackenbush, E. J , Vere, S , Greaves, A., and Letarte, M Confirmation by peptide sequence and co-expression on various cell types of the identity of CD44 and p85 glycoprotein Mol Immunol., 27: 947-955, 1990
28. Davidson, R. L., and Gerald, P. S. Improved techniques for the induction of mammalian cell hybridization by polyethylene glycol. Somatic Cell Genet , 2. 165-176, 1976.
29. Gross-Bellard, M., Oudet, P , and Chambon, B. Isolation of high-molecular-weight DNA from mammalian cells. Eur J. Biochem , 36 32-38, 1973
30. Ben-David, Y., Giddens, E., and Bernstein, A. Identification and mapping of a common proviral integration site Flt-1 in erythroleukemic cells induced by Friend murine leukemia virus. Proc. Natl Acad. Sci. USA, 87. 1332-1336, 1990.
31. Trent, J. M., and Thompson, F H Methods for chromosome banding of human and experimental tumors in vitro. Methods Enzymol., 151: 267-279, 1987
32. Edward, M. Integrins and other adhesion molecules involved in melanocytic tumor progression. Curr. Opin. Oncol., 7: 185-191, 1995.
33. Albeda, S. M., Mette, S. A., Edler, D. A , Stewart, R , Damjanovich, L., Herlyn, M., and Buck, G A Integrin distribution in malignant melanoma association of the β3 subunit with tumor progression. Cancer Res , 50. 6757-6764, 1990
34. Sers, C., Riethmuller, G , and Johnson, J. P MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread Cancer Res , 54: 5689-5694, 1994.
35. Johnson, J P., Rothbacher, U , and Sers, C The progression associated antigen MUC18 a unique member of the immunoglobulin supergene family. Melanoma Res , 3: 337-340, 1993.
36. Luca, M , Hunt, B., Bucana, C. D., Johnson, J. P , Fidler, I J , and Bar-Eli, M Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res , 3: 35-41, 1993
37. Rodeck, U., Herlyn, M., Menssen, H D , Furlanetto, R. W , and Koprowski, H. Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors Int. J. Cancer, 40: 687-690, 1987.
38. Kerbel, R. S Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer: malignant melanoma as a paradigm. Am. J. Pathol., 141. 519-524, 1992.
39. Lu, C., Rak, J. W , Kobayashi, H., and Kerbel, R. S. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions Cancer Res., 53: 2708-2711, 1993
40. Lu, C., and Kerbel, R. S. Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma Curr Opin Oncol., 6: 212-220, 1994.
41. Silvani, A , Ferrari, G., Paonessa, G., Toniatu, C., Parmiani, G , and Colombo, M P. Down regulation of IL-6Rα chain in IL-6 transduced melanoma cells causes selective resistance to IL-6 but not to oncostatin M. Cancer Res., 55: 2200-2205, 1995
42. Ben-David, Y., Prideaux, V. R., Chow, V., Benchimol, S., and Bernstein, A. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythro-leukemic cell lines induced by Friend leukemia virus. Oncogene, 3: 179-185, 1988.
43. Kung, H. J , Soerkoel, C., and Carter, T. H. Retroviral mutagenesis of cellular oncogenes: a review. Insights into the mechanisms of insertional activation. Curr. Top. Microbiol. Immunol., 71: 1-25, 1991.
44. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990
45. Halaban, R. Molecular correlates in the progression of normal melanocytes to melanomas. Semin. Cancer Biol., 4: 171-181, 1993.
46. Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M., and Massagué, J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation Cell, 62: 175-185, 1990
47. Gerwin, B I, Spillare, E , Forrester, K., Lehman, T. A., Kispert, J., Welsh, J. A., Pfeifer, A. M., Lechner, J. F., Baker, S. J., Vogelstein, B , and Harris, C. C. Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor β1. Proc Natl. Acad. Sci. USA, 89: 2759-2763, 1992.
48. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994.
49. Vidal, M J., Loganzo, F., de Oliverira, A. R , Hayward, N K., and Albino, A. P. Mutations and defective expression of the WAF1 P21 tumour-suppressor gene in malignant melanomas Melanoma Res , 5: 243-250, 1995.
50. Halaban, R., Kwon, B , Ghosh, S., Delli Bovis, P., and Baird, A. bFGF as an autocrine growth factor for human melanocytes. Oncogene Res., 3: 177-186, 1988.
51. Dotto, G. P, Moellmann, G., Ghosh, S , Edwards, M., and Halaban, R. Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment J Cell Biol., 109: 3115-3128, 1989.
52. Cajal, S. R., Suster, S., Halaban, R., Filvaroff, E., and Dotto, G. P. Induction of different morphologic features of malignant melanoma and pigmented lesions after transformation of murine melanocytes with bFGF-cDNA and H-ras, myc, neu, and EIa oncogenes. Am. J. Pathol., 138: 349-358, 1991.
53. Rodeck, U., Becker, D., and Herlyn, M Basic fibroblast growth factor in human melanomas. Cancer Cells, 3: 308-311, 1991.
54. Folkman, J., and Klagsbrun, M Angiogenic factors. Science (Washington DC), 235: 442-447, 1987.
55. Lu, C , and Kerbel, R S. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J. Cell Biol., 120: 1281-1288, 1993.
56. Albino, A. P., Houghton, A. N., Eisinger, M., Lee, J. S., Kantor, R. S , Oliff, A. I., and Old, L. J. Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma (HA-MSV) and Kirsten MSV retroviruses. J. Exp. Med. 164: 1710-1722, 1986.
57. Kerbel, R. S., Cornil, I , Man, M. S., and Ishikawa, M. Importance of orthotopic transplantation procedures in assessing the effects of transfected genes on human tumor growth and metastasis. Cancer Metastasis Rev., 10: 201-215, 1991.